Great posts Adreamer,
Finally an appropriate level of positivity for a company that has finally has achieved what every long term shareholder wanted and expected from this amazing drug. Extremely positive (potentially amazing) results in Human trialling (resulting in it 4-bagging).
It is the first time I have placed a poster on ignore due to relentless and irrational negativity.
DrMT has done an amazing job since arriving in the role and said he had calls scheduled to Major Investment Banks that specialise in M&A following results drop to find a partner. These M&A specialists will use these trial results and all the preclinical data we have from ONJCRI, WEHI (COVID and HTLV-1), 360 Biolabs and now Clinical data analysed by Berry Consulting to get what he hopes is a partner moving forward which is worth at a Minimum 2.4 Billion USD (Thanks Adreamer for asking that question on the PharmAust Investor Hub). Dr Thomas Duthy is not here for his good looks. He has experience in this area, and will be working to get the best deal, whatever the form it takes.
Remember though, as @NZTrader says, big pharma will “take it whichever way they want” . DrMT says, get all the information to all the Big and Medium Pharma that could be interested so that there is a “Bidding war” created. This is as close to our terms as we will probably see.
Very exciting times…
Havelots
- Forums
- ASX - By Stock
- PharmAust media thread
Great posts Adreamer,Finally an appropriate level of positivity...
- There are more pages in this discussion • 149 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $91.02K | 417.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 119713 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2325 | 0.215 |
7 | 63630 | 0.210 |
4 | 193228 | 0.205 |
9 | 159603 | 0.200 |
4 | 276128 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 119713 | 2 |
0.230 | 24215 | 3 |
0.235 | 50000 | 1 |
0.240 | 44200 | 1 |
0.245 | 55000 | 4 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
22.0¢ |
  |
Change
0.000 ( 5.72 %) |
|||
Open | High | Low | Volume | ||
23.0¢ | 23.0¢ | 21.0¢ | 271600 | ||
Last updated 15.42pm 06/05/2024 ? |
Featured News
PAA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online